Abnormal Glial Cell Morphology C4021993
A structural abnormality in support cells of the nervous system. These cells help protect neurons, and abnormalities may be associated with neurological conditions.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Sudden, uncontrolled electrical disturbances in the brain causing convulsions, muscle spasms, or loss of consciousness.
Seek emergency care immediately for any seizure lasting more than 5 minutes or if the person does not wake up between seizures.
Speech difficulties
Slurred speech, difficulty finding words, or trouble understanding spoken language.
Seek emergency care immediately if speech difficulties occur suddenly, as this may indicate a stroke.
Headache
(neurologic)Persistent or worsening headache, often described as dull, throbbing, or pressure-like, which may be worse in the morning.
Frequency: 70-80% of patients
Fatigue
(constitutional)Persistent tiredness and lack of energy that interferes with daily activities and does not improve with rest.
Frequency: 60-70% of patients
Numbness or tingling
(neurologic)Abnormal sensations including pins-and-needles feeling, numbness, or reduced sensation in extremities or face.
Frequency: 45-55% of patients
Muscle weakness
(neurologic)Reduced muscle strength making it difficult to perform tasks that require physical effort or maintain balance.
Frequency: 40-50% of patients
Visual disturbances
(neurologic)Blurred vision, double vision, or partial vision loss that may affect one or both eyes.
Frequency: 20-30% of patients
Balance problems
(neurologic)Difficulty with coordination, unsteady walking, or frequent falls due to impaired balance and spatial orientation.
Frequency: 35-45% of patients
Cognitive changes
(neurologic)Difficulty with memory, concentration, or thinking clearly that affects daily functioning and decision-making.
Frequency: 25-35% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Neuroimaging follow-up
Regular MRI or CT imaging to monitor glial cell abnormalities and detect any progression or associated neurological changes over time.
Neuroprotective and anti-inflammatory therapy
Pharmacological intervention targeting neuroinflammation and providing neuroprotection to support normal glial cell function and prevent further abnormalities.
Additional treatment options
Neurorehabilitation program
Targeted physical therapy addressing motor and sensory symptoms associated with glial abnormalities, focusing on functional recovery and independence.
physical_therapyNeuropsychological support
Cognitive assessment and therapeutic support to address any cognitive changes associated with glial cell pathology and provide coping strategies.
psychologicalBrain-healthy lifestyle modifications
Comprehensive lifestyle program including stress management, adequate sleep, and cognitive stimulation to support glial cell health and brain function.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Glial Cell Morphology C4021993?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7-35.
Pekny M, Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev. 2014;94(4):1077-1098.
Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91(2):461-553.
Wang Y, Qin ZH. Molecular and cellular mechanisms of excitotoxicity in acute neural injury. Neurosci Bull. 2011;27(5):307-316.
Brambilla L. Microglia activation and gliosis: physiological and pathological mechanisms. Neural Regen Res. 2022;17(12):2627-2634.
Love S, Budka H, Ironside JW, Perry A. Greenfield's Neuropathology. 9th ed. CRC Press; 2015.
Escartin C, Galea E, Lakatos A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312-325.
Wahl AS, Buchthal B, Rode F, et al. Hypoxic/ischemic brain injury: pathophysiology and neuroprotective strategies. Handb Clin Neurol. 2023;195:3-31.
Medication Comparisons
Compare medications used to treat Abnormal Glial Cell Morphology C4021993. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy